Split D.C. Circuit Limits False Claims Act Liability Under Federal Grants
Client Alert | 1 min read | 09.17.04
In U.S. ex rel. Totten v. Bombardier Corp. (Aug. 27, 2004), a divided D.C. Circuit upheld dismissal of a qui tam complaint alleging that a contractor for a federal grantee had submitted false claims to the grantee, reasoning that presentation of the claims to (and their payment by) the federal grantee did not, by itself, satisfy the FCA provision that actionable claims be "presented to an officer or employee of the … Government" (31 USC 3729(a)(1), emphasis added), or the alternate FCA provision imposing liability for a false record made in order to get a false claim "paid or approved by the Government" ((31 USC 3729(a)(2), emphasis added). The dissent argued vigorously that the consequence of the majority's opinion is a "dramatic cutback" in FCA coverage because it would preclude liability in the common situation where a grantee is not required to seek Government approval before paying a contractor's invoice.
Insights
Client Alert | 4 min read | 01.07.26
On December 17, 2025, the U.S. Food and Drug Administration (FDA) issued a request for information (RFI) on a proposal designed to help the FDA engage more directly with innovative, venture-backed companies focused on biotechnology, medical devices, AI, and regulatory technology.[i]The RFI includes 19 questions, with responses due by 2:00 p.m. ET on January 18, 2026.
Client Alert | 3 min read | 01.07.26
CMMC for AI? Defense Policy Law Imposes AI Security Framework and Requirements on Contractors
Client Alert | 3 min read | 01.07.26
New Year, Same CIPA Uncertainty – When Will the Appellate Courts Enter the Chat?
Client Alert | 11 min read | 01.07.26
